Page last updated: 2024-09-05

erlotinib hydrochloride and Hair Diseases

erlotinib hydrochloride has been researched along with Hair Diseases in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	1 (16.67)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Chan, JYY; Kwok, TYT; Yuen, HKL	1
Bangerter, M; Brudler, O; Heinrich, B; Reimer, G	1
Dirschka, T; Hauschild, A; Kroth, J; Wollenberg, A	1
Lacouture, ME; Mitchell, EP; Perez-Soler, R; Van Cutsem, E	1
Gerber, PA; Homey, B	1
Burgin, S; Heidary, N; Naik, H	1

Reviews

3 review(s) available for erlotinib hydrochloride and Hair Diseases

Article	Year
[Cutaneous side effects of EGFR inhibitors--appearance and management]. Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:4 Topics: Acneiform Eruptions; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Hair Diseases; Humans; Ichthyosis; Mucositis; Neoplasms; Panitumumab; Paronychia; Protein Kinase Inhibitors; Quinazolines	2010
Clinical presentation and pathophysiology of EGFRI dermatologic toxicities. Oncology (Williston Park, N.Y.), 2007, Volume: 21, Issue:11 Suppl 5 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Hair Diseases; Humans; Lapatinib; Nail Diseases; Panitumumab; Protein Kinase Inhibitors; Quinazolines; Telangiectasis	2007
Chemotherapeutic agents and the skin: An update. Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites; Antineoplastic Agents; Benzamides; Benzenesulfonates; Cetuximab; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; ErbB Receptors; Erlotinib Hydrochloride; Fusion Proteins, bcr-abl; Gefitinib; Hair Diseases; Humans; Imatinib Mesylate; Indoles; Mucous Membrane; Nail Diseases; Niacinamide; Phenylurea Compounds; Piperazines; Platinum Compounds; Proteasome Inhibitors; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Signal Transduction; Skin; Skin Diseases; Sorafenib; Sunitinib; Taxoids	2008

Other Studies

3 other study(ies) available for erlotinib hydrochloride and Hair Diseases

Article	Year
Eyelash trichomegaly induced by erlotinib for metastatic lung cancer. Hong Kong medical journal = Xianggang yi xue za zhi, 2021, Volume: 27, Issue:1 Topics: Aged; Antineoplastic Agents; Erlotinib Hydrochloride; Eyelashes; Eyelid Diseases; Female; Hair Diseases; Humans; Lung Neoplasms	2021
[EGFR (epidermal growth factor receptor) inhibitor-associated skin disorders in tumor therapy]. MMW Fortschritte der Medizin, 2008, Dec-04, Volume: 150, Issue:49-50 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Diagnosis, Differential; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Hair Diseases; Humans; Neoplasms; Quinazolines	2008
Images in clinical medicine. Erlotinib-induced hair alterations. The New England journal of medicine, 2008, Mar-13, Volume: 358, Issue:11 Topics: Erlotinib Hydrochloride; Hair Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines	2008